Metaproterenol Inhalation Clinical Trials

• Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood
  ClinicalTrials.gov Identifier: NCT00116311 - Active, not recruiting
  Asthma; Healthy
  
• NO Donors and Inhibitors Study
  ClinicalTrials.gov Identifier: NCT00159380 - Recruiting
  Asthma; Healthy volunteers
  
• Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
  ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
  Cystic Fibrosis
  
• Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00388505 - Recruiting
  Cystic Fibrosis
  
• The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
  ClinicalTrials.gov Identifier: NCT00060840 - Recruiting
  Congestive Heart Failure
  
• Staccato® Prochlorperazine for Inhalation in Migraine
  ClinicalTrials.gov Identifier: NCT00422812 - Active, not recruiting
  Migraine Headache; Aura
  
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Sallmeterol Inhalation Aerosol.
  ClinicalTrials.gov Identifier: NCT00274560 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00232648 - Active, not recruiting
  Asthma
  
• A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
  ClinicalTrials.gov Identifier: NCT00274534 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Human Insulin Inhalation Powder in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00325364 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males
  ClinicalTrials.gov Identifier: NCT00475371 - Active, not recruiting
  Diabetes Mellitus, Type 2; Healthy Males
  
• Study of Dust Mite Inhalation in Humans
  ClinicalTrials.gov Identifier: NCT00448851 - Recruiting
  Mild Asthma; Allergy
  
• Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics
  ClinicalTrials.gov Identifier: NCT00527462 - Recruiting
  Asthma
  
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00332488 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
  ClinicalTrials.gov Identifier: NCT00265434 - Active, not recruiting
  Cystic Fibrosis; Chronic Rhinosinusitis
  
• Staccato® Loxapine for Inhalation in Patients With Migraine Headache
  ClinicalTrials.gov Identifier: NCT00489476 - Recruiting
  Migraine
  
• Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients with Non-Small-Cell Lung Carcinoma (NSCLC)
  ClinicalTrials.gov Identifier: NCT00082472 - Active, not recruiting
  NSCLC
  
• Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00425165 - Recruiting
  Cystic Fibrosis
  
• Effects of Acetazolamide and CO2 Inhalation on Exercise-Induced Periodic Breathing in Heart Failure
  ClinicalTrials.gov Identifier: NCT00517426 - Recruiting
  Chronic Heart Failure
  
• Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
  ClinicalTrials.gov Identifier: NCT00551642 - Recruiting
  Lung Disease
  
• The “VISION” Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00302211 - Recruiting
  Pulmonary Hypertension
  
• A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function with Tiotropium (Spiriva®) 18 Mcg Inhalation Capsule Once Daily in Patients with Chronic Obstructive Pulmonary Disaese (COPD).
  ClinicalTrials.gov Identifier: NCT00144339 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00558844 - Recruiting
  Cystic Fibrosis
  
• Efficacy of Tiotropium in Patients of African Descent with Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00106821 - Active, not recruiting
  Chronic Obstructive Pulmonary Disease
  
• Budesonide Inhalation Suspension for Acute Asthma in Children
  ClinicalTrials.gov Identifier: NCT00393367 - Recruiting
  Asthma; Acute Asthma; Reactive Airway Exacerbation
  
• Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome
  ClinicalTrials.gov Identifier: NCT00378677 - Recruiting
  Lung Transplantation; Bronchiolitis Obliterans
  
• Dose-Ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis
  ClinicalTrials.gov Identifier: NCT00504426 - Recruiting
  Pain Due to Osteoporosis
  
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
  Cystic Fibrosis
  
• Staccato™ Alprazolam for Inhalation in Panic Attack
  ClinicalTrials.gov Identifier: NCT00477451 - Recruiting
  Panic Attack
  
• A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects with Persistent Asthma
  ClinicalTrials.gov Identifier: NCT00116103 - Completed
  Asthma
  
• Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
  ClinicalTrials.gov Identifier: NCT00534079 - Recruiting
  Cystic Fibrosis; Rhinosinusitis
  
• The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc 15 Setting
  ClinicalTrials.gov Identifier: NCT00467896 - Recruiting
  Pulmonary Hypertension
  
• Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00523991 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00006280 - Completed
  Cystic Fibrosis
  
• Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
  ClinicalTrials.gov Identifier: NCT00162487 - Recruiting
  Hyperkalemia; Chronic Renal Failure
  
• Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
  ClinicalTrials.gov Identifier: NCT00309244 - Recruiting
  Diabetes Mellitus, Type 2
  
• Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
  ClinicalTrials.gov Identifier: NCT00102531 - Recruiting
  Osteosarcoma
  
• Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
  ClinicalTrials.gov Identifier: NCT00094887 - Recruiting
  Anemia, Sickle Cell
  
• Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. aeruginosa
  ClinicalTrials.gov Identifier: NCT00104520 - Completed
  Cystic Fibrosis
  
• International Safety and Efficacy Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00112359 - Completed
  Cystic Fibrosis
  
• Preprocedural Fasting and Nitrous Oxide -Oxygen Inhalation Analgesia for Dental Treatment of Children
  ClinicalTrials.gov Identifier: NCT00263289 - Not yet recruiting
  Vomiting
  
• A 12-Week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18µg q.d. in Patients with COPD and a Concomitant Diagnosis of Asthma
  ClinicalTrials.gov Identifier: NCT00152984 - Completed
  Pulmonary Disease, Chronic Obstructive; Asthma
  
• Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
  ClinicalTrials.gov Identifier: NCT00144846 - Recruiting
  acute wheezing obstructive airways disease
  
• Dornase Alfa Inhalation Solution or a Placebo in Treating Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Radiation Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00536952 - Not yet recruiting
  Head and Neck Cancer
  
• Endotoxin and Inflammatory Markers
  ClinicalTrials.gov Identifier: NCT00159289 - Recruiting
  Mild to moderate Chronic Obstructive Pulmonary Disease (COPD); Volunteers (healthy non-smokers); Volunteers (current or ex-smokers)
  
• Efficacy and Safety of Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects
  ClinicalTrials.gov Identifier: NCT00125346 - Suspended
  Cystic Fibrosis
  
• Staccato® Alprazolam for Inhalation in Panic Disorder
  ClinicalTrials.gov Identifier: NCT00444522 - Completed
  Healthy
  
• StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
  ClinicalTrials.gov Identifier: NCT00369577 - Completed
  Schizophrenia
  
• Staccato® Fentanyl for Inhalation in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00402350 - Completed
  Breakthrough Pain
  
• Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
  ClinicalTrials.gov Identifier: NCT00512811 - Completed
  Bronchiolitis
  
• The Correlation Between Airway Inflammation and Loss of Deep Inhalation Bronchoprotection in Asthmatics
  ClinicalTrials.gov Identifier: NCT00404677 - Completed
  Asthma
  
• A Pharmacokinetic and Bioavailability Study of Mannitol for Inhalation Using Normal Subjects
  ClinicalTrials.gov Identifier: NCT00446771 - Completed
  Healthy Volunteers
  
• Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.
  ClinicalTrials.gov Identifier: NCT00192959 - Completed
  Anaesthesia; Postoperative Cognitive Function
  
• Tobramycin Inhalation Solution Administered by eFlow Rapid Nebulizer: Scintigraphy Study
  ClinicalTrials.gov Identifier: NCT00399945 - Completed
  Cystic Fibrosis
  
• Tiotropium Inhalation Capsules and Atrovent MDI Comparison Trial in Taiwan
  ClinicalTrials.gov Identifier: NCT00274092 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• ATP/AMP Challenge in Healthy, Smokers, Asthma, COPD
  ClinicalTrials.gov Identifier: NCT00159315 - Recruiting
  Healthy Volunteers (smokers); Healthy Volunteers (Non-smokers); Asthma Patients; COPD patients
  
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
  ClinicalTrials.gov Identifier: NCT00239447 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
  ClinicalTrials.gov Identifier: NCT00281567 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Efficacy and Safety (Including 24-Hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD
  ClinicalTrials.gov Identifier: NCT00239460 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00418509 - Completed
  Healthy
  
• Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis
  ClinicalTrials.gov Identifier: NCT00263315 - Completed
  Aspergillosis
  
• Staccato® Loxapine for Inhalation in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00444028 - Completed
  Schizophrenia
  
• The Effects of Long Term Inhalation of Hypertonic Saline in Subjects With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00271310 - Completed
  Cystic Fibrosis
  
• Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00539890 - Completed
  Diabetes Type 2
  
• Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00567775 - Completed
  Type 1 Diabetes Mellitus
  
• Monoclonal Antibody for Treatment of Inhalation Anthrax
  ClinicalTrials.gov Identifier: NCT00138411 - Completed
  Bacillus anthracis (anthrax)
  
• A 3-Week Multicenter Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients with Asthma
  ClinicalTrials.gov Identifier: NCT00130351 - Completed
  Asthma
  
• Comparing Intensive and Standard Training for Human Insulin Inhalation Powder (HIIP)
  ClinicalTrials.gov Identifier: NCT00099515 - Completed
  Diabetes Mellitus, Type 2
  
• Aerosolized Randomized Iloprost Study II (AIR – II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00414687 - Completed
  Pulmonary Hypertension
  
• Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00250679 - Completed
  Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema
  
• Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00465959 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00056147 - Completed
  Cystic Fibrosis
  
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00239434 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Safety and Efficacy of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus.
  ClinicalTrials.gov Identifier: NCT00063128 - Completed
  Diabetes Mellitus, Type 1
  
• Sevoflurane vs Isoflurane Inhalation at Subanesthetic Concentrations - 11
  ClinicalTrials.gov Identifier: NCT00000259 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• A Randomized, Double Blind, Placebo Controlled Trial to Compare the Effect of Tiotropium Inhalation Capsules (Spiriva, Bromuro De Tiotropio) on Exercise Tolerance in Patients with COPD Participating in 8 Weeks of Pulmonary Rehabilitation
  ClinicalTrials.gov Identifier: NCT00157235 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Inhaled Iloprost in Adults with Abnormal Pulmonary Pressure and Associated with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00109681 - Completed
  Pulmonary Fibrosis; Pulmonary Hypertension
  
• Inhaled Nitric Oxide in Neonates with Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation
  ClinicalTrials.gov Identifier: NCT00041548 - Completed
  Lung Disease; Hypoxemia; Respiratory Acidosis
  
• Nitric Oxide Inhalation Therapy to Relieve Chest Pain in Patients with Coronary Artery Disease
  ClinicalTrials.gov Identifier: NCT00014040 - Completed
  Coronary Disease; Myocardial Ischemia
  
• A Randomised, Double-Blind, Placebo-Controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients with Chronic Obstructive Pulmonary Disease (COPD).
  ClinicalTrials.gov Identifier: NCT00144326 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation
  ClinicalTrials.gov Identifier: NCT00060450 - Completed
  Ischemia-Reperfusion Injury
  
• Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14
  ClinicalTrials.gov Identifier: NCT00000262 - Completed
  Opioid-Related Disorders; Substance-Related Disorders
  
• Interferon gamma-1b by inhalation for the treatment of patients with cystic fibrosis
  ClinicalTrials.gov Identifier: NCT00043316 - Completed
  Cystic Fibrosis
  
• Phase III Randomized Study of the Inhalation of Tobramycin in Patients with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00004829 - Completed
  Cystic Fibrosis; Bacterial Infection
  
• Nocturnal Oxygen Therapy
  ClinicalTrials.gov Identifier: NCT00000564 - Completed
  Lung Diseases; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Evaluation of Pain Intensity During Bone Marrow Biopsy Performed With Inhalation of Pre-Mixed 50 Per Cent Nitrous Oxide and Oxygen Mixture.
  ClinicalTrials.gov Identifier: NCT00219713 - Terminated
  Pain
  
• ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment
  ClinicalTrials.gov Identifier: NCT00322803 - Terminated
  Panic Disorder
  
• Ribavirin to prevent RSV pneumonia in Bone Marrow Transplant patients
  ClinicalTrials.gov Identifier: NCT00031473 - Terminated
  Respiratory Syncytial Virus Infections
  
• Effects of Inhaled Nitric Oxide in the Treatment of Acute Hypoxemic Respiratory Failure (AHRF) in Pediatrics
  ClinicalTrials.gov Identifier: NCT00041561 - Terminated
  Respiratory Insufficiency; Anoxemia
  
• Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
  ClinicalTrials.gov Identifier: NCT00041574 - Terminated
  Pulmonary Hypertension; Lung Disease; Sickle Cell Disease; Cardiac transplant; Lung transplant